SCHEMBL30295197

SCHEMBL30295197

Brc1c[nH]c2ccncc12

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 3/20 0.59
HASPIN Q8TF76 3/20 0.59
CCNT1 O60563 1/20 0.59
CDK9 P50750 1/20 0.59
HTR6 P50406 2/20 0.51
AXL P30530 2/20 0.46
GSK3B P49841 3/20 0.43
DYRK1A Q13627 3/20 0.43
NFATC1 O95644 2/20 0.43
ACHE P22303 3/20 0.42
IMPDH2 P12268 2/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GPR84 Q9NQS5 1/20 0.38
PARP1 P09874 1/20 0.38
PDPK1 O15530 1/20 0.38
TGFBR1 P36897 1/20 0.38
IKBKE Q14164 1/20 0.38
TDO2 P48775 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10587 1.00 PIM1 (0.59) PIM1HASPINCCNT1CDK9HTR6
SCHEMBL29814872 0.83 PIM1 (0.59) PIM1HASPINCCNT1CDK9AXL
SCHEMBL1892610 0.83 PIM1 (0.59) PIM1HASPINCCNT1CDK9AXL
SCHEMBL16168495 0.75 HTR6 (0.56) PIM1HASPINCCNT1CDK9HTR6
SCHEMBL2050489 0.75 HASPIN (0.59) PIM1HASPINCCNT1CDK9HTR6
SCHEMBL30067091 0.75 HASPIN (0.59) PIM1HASPINCCNT1CDK9HTR6
SCHEMBL14059758 0.75 GSK3B (0.51) PIM1HASPINCCNT1CDK9HTR6
SCHEMBL3224448 0.75 ATM (0.52) PIM1HASPINCCNT1CDK9HTR6
SCHEMBL29535106 0.75 ATM (0.52) PIM1HASPINCCNT1CDK9HTR6
SCHEMBL15634812 0.75 GSK3B (0.48) PIM1HASPINCCNT1CDK9AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026090330-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2026-04-30 WO disclosed
WO-2024220891-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2024-10-24 WO disclosed
CN-113924301-B Pyrazolopyrazine derivative compound, pharmaceutical composition and application thereof 北京普祺医药科技股份有限公司 2024-08-16 CN disclosed
EP-4408850-A1 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE Caraway Therapeutics, Inc. (US) 2024-08-07 EP disclosed
EP-4408849-A1 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE Caraway Therapeutics, Inc. (US) 2024-08-07 EP disclosed
CN-118317963-A TRPML modulators, compositions thereof, and methods of use 卡拉韦治疗公司 2024-07-09 CN disclosed
WO-2023055912-A1 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE CARAWAY THERAPEUTICS, INC. (US) 2023-04-06 WO disclosed
WO-2023055920-A1 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE CARAWAY THERAPEUTICS, INC. (US) 2023-04-06 WO disclosed